749
GLP-1 AGONISTS CAN PREVENT LIVER DISEASE PROGRESSION IN PATIENTS WITH METABOLIC AND ALCOHOL-ASSOCIATED LIVER DISEASE (METALD).
Date
May 20, 2024
Tracks
Related Products
Point-of-Care-Ultrasound (POCUS) in Hepatology $$$(AAPC)
This symposium will introduce the concept of point of care ultrasound (POCUS) of the liver as an extension of the clinical exam to be performed by hepatology providers…
AMONG PATIENTS WITH IBD USE OF STATINS IS ASSOCIATED WITH LOWER RISK OF DEVELOPING DE NOVO PRIMARY SCLEROSING CHOLANGITIS
BACKGROUND: Primary sclerosing cholangitis (PSC) is a progressive, cholestatic liver disease without medical cure, that confers a significantly elevated risk of malignancy, acute cholangitis and cirrhosis. Approximately 2-7% of patients with inflammatory bowel disease (IBD) will develop PSC…